|
Vir Biotechnology Inc (VIR) |
|
|
|
VIR's Revenue Growth by Quarter and Year
Vir Biotechnology Inc 's Revenue results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
VIR Revenue (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
IV Quarter |
December |
49.41
|
812.76
|
1.73
|
-1.40
|
III Quarter |
September |
374.56
|
103.62
|
1.93
|
1.40
|
II Quarter |
June |
-40.63
|
177.07
|
66.99
|
0.00
|
I Quarter |
March |
1,232.46
|
1.98
|
5.72
|
0.00
|
FY |
|
1,615.80
|
1,095.43
|
76.37
|
0.00
|
VIR Revenue fourth quarter 2022 Y/Y Growth Comment |
Vir Biotechnology Inc reported drop in Revenue in the fourth quarter 2022 by -93.92% to $ 49.41 millions, from the same quarter in 2021. The fall in the fourth quarter 2022 Vir Biotechnology Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 10436.45%.
Among companies who have reported fourth quarter 2022 results in the Biotechnology & Pharmaceuticals industry only one Company has achieved higher year on year Revenue results in the fourth quarter 2022. While Vir Biotechnology Inc ' s Revenue meltdown of -93.92% ranks overall at the positon no. 10 in the fourth quarter 2022.
|
VIR Revenue ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
IV Quarter |
December |
-93.92 % |
46880.35 % |
- |
- |
III Quarter |
September |
261.47 % |
5268.91 % |
37.86 % |
- |
II Quarter |
June |
- |
164.32 % |
- |
- |
I Quarter |
March |
62145.45 % |
-65.38 % |
- |
- |
FY |
|
47.5 % |
1334.37 % |
- |
- |
VIR Revenue (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
IV Quarter |
December |
-86.81 % |
684.37 % |
-10.36 % |
- |
III Quarter |
September |
- |
-41.48 % |
-97.12 % |
- |
II Quarter |
June |
- |
8842.93 % |
1071.15 % |
- |
I Quarter |
March |
51.64 % |
14.45 % |
- |
- |
FY (Year on Year) |
|
47.5 % |
1334.37 % |
- |
- |
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
46771.68 % |
10436.45 % |
-65.44 % |
(Dec 31 2021) |
|
(Mar 31 2021) |
|
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
46771.68 % |
10436.45 % |
-65.44 % |
(Dec 31 2021) |
|
(Mar 31 2021) |
|
Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Vir Biotechnology Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
8860.93 % |
1497.45 % |
-97.12 % |
(Jun 30 2021) |
|
|
VIR's IV. Quarter Q/Q Revenue Comment |
In the IV. Quarter 2022 Vir Biotechnology Inc realized fall in Revenue from the third quarter by -86.81% to $ 49.41 millions, from $ 374.56 millions declared a quarter before.
Albeit cyclical circumstance commonly elevate IV. Quarter 2022 Revenue, this plainly has not been sufficient to salvage Biotechnology & Pharmaceuticals's company IV. Quarter 2022 achievement, Amy Davis, an industry contributor allocated in Dallas said and continued that average sequential Revenue growth is at 1497.45% for VIR.
Within Biotechnology & Pharmaceuticals industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Vir Biotechnology Inc 's Revenue growth quarter on quarter, overall rank is 57. |
|
|
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
8860.93 % |
1497.45 % |
-97.12 % |
(Jun 30 2021) |
|
|
VIR's IV. Quarter Q/Q Revenue Comment |
In the IV. Quarter 2022 Vir Biotechnology Inc reported fall in Revenue from the previous quarter by -86.81% to $ 49.41 millions, from $ 374.56 millions declared a quarter before.
Albeit cyclical circumstance usually energize IV. Quarter 2022 Revenue, it simply could not be enough to recover Biotechnology & Pharmaceuticals's company IV. Quarter performance, Amy Davis, an industry contributor allocated in Dallas pointed out.
Within Biotechnology & Pharmaceuticals industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Vir Biotechnology Inc 's Revenue growth quarter on quarter, overall rank is 57. |
|
Vir Biotechnology Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending (Dec 31 2022) |
12 Months Ending (Sep 30 2022) |
12 Months Ending (Jun 30 2022) |
12 Months Ending (Mar 31 2022) |
12 Months Ending (Dec 31 2021) |
Cumulative Revenue 12 Months Ending |
$ 1,615.80 |
$ 2,379.14 |
$ 2,108.20 |
$ 2,325.90 |
$ 1,095.42 |
Y / Y Revenue Growth (TTM) |
47.51 % |
736.57 % |
1053.88 % |
3102.57 % |
1334.39 % |
Year on Year Revenue Growth Overall
Ranking |
# 33 |
# 134 |
# 199 |
# 0 |
# 0 |
Seqeuential Revenue Change (TTM) |
-32.08 % |
12.85 % |
-9.36 % |
112.33 % |
285.18 % |
Seq. Revenue Growth (TTM) Overall
Ranking |
# 34 |
# 1907 |
# 2461 |
# 2334 |
# 2682 |
Cumulative Revenue growth
Comment |
With the quarterly Revenue reported in the Dec 31 2022 period, Vir Biotechnology Inc 's cumulative twelve months Revenue were $ 1,616 millions, company would post below average annual Revenue growth of 285.18% year on year, if the fiscal year would end at Dec 31 2022. A slow-down in the Vir Biotechnology Inc 's Revenue growth from the 374.56% growth in Sep 30 2022.
Among companies within the Healthcare sector 11 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 33, from total ranking in previous quarter at 134. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
285.18 % |
82.08 % |
-4.9 % |
|
|
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
1334.39 % |
591.35 % |
151.29 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 7 |
Sector |
# 10 |
S&P 500 |
# 34 |
|
Cumulative Revenue growth
Comment |
With the quarterly Revenue reported in the Dec 31 2022 period, Vir Biotechnology Inc 's cumulative twelve months Revenue were $ 1,616 millions, company would post below average annual Revenue growth of 151.29% year on year, if the fiscal year would end at Dec 31 2022. A slow-down in the Vir Biotechnology Inc 's Revenue growth from the 374.56% growth in Sep 30 2022.
Among companies within the Healthcare sector 11 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 33, from total ranking in previous quarter at 134. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
285.18 % |
82.08 % |
-4.9 % |
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
1334.39 % |
591.35 % |
151.29 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 7 |
Sector |
# 10 |
S&P 500 |
# 34 |
|